Importantly, prevention of proteasomal degradation of misfolded proteins by an inhibitor of mannosidase-I kifunensine successfully reduced CPVT occurrence in TRDN-KO mice [13]. This evidence concerns the gene TRDN and catecholaminergic polymorphic ventricular tachycardia.